DONEPEZIL f.c. tablets

Strength: (0.3 mg+5 mg)/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Ganfort (Allergan)

Strength: 0.3 mg/ml; 0.1 mg/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Lumigan (Allergan)

Strength: (2 mg+5 mg)/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Combigan (Allergan)

Strength: 2 mg/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Alphagan (Allergan)

Strength: 1 mg/ml Presentation: vials, 5 ml Therapeutic area: Treatment of inflammatory conditions of the anterior segment of the eye Innovator: Dexafree (Laboratoires THEA)

Strength:  0.5 mg/tab; 2 mg/tab; 4 mg/tab; 8 mg/tab; 10 mg/tab; 20 mg/tab Therapeutic area: Glucocorticoid Therapy Innovator: - (-)

Strength: 1 mg/ml Presentation: bottles, 150 ml Therapeutic area: Alzheimer's Dementia Innovator: Aricept (Pfizer)

Strength: (20 mg+5 mg)/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Cosopt (Merk & Co)

Strength: 20 mg/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Trusopt (Merk & Co)

Strength: 0.5 mg/cap Therapeutic area: Benign Prostatic Hyperplasia Innovator: Avodart (GSK)

Strength: 20 mg/tab; 40 mg/tab; 80 mg/tab Therapeutic area: Migraine Treatment Innovator: Relpax (Pfizer)

Strength: 10 mg/tab Therapeutic area: Primary Hypercholesterolaemia, Homozygous Familial Hypercholesterolaemia, Homozygous Sitosterolaemia Innovator: Ezetrol (Merck & Co)